reported an increase in connective tissue growth factor (CTGF) mRNA with reduced sensitivity to tamoxifen in breast cancer cells cocultured with mammary adipocytes under conditions of high glucose, an effect that was reversed by inhibiting adipocyte-derived interleukin 8 (IL8) (65). This evidence concerns the gene CCN2 and breast cancer.